Second degree AV block primary prevention
|
Second degree AV block Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Second degree AV block primary prevention On the Web |
|
American Roentgen Ray Society Images of Second degree AV block primary prevention |
|
Risk calculators and risk factors for Second degree AV block primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels. Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing. Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system. By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
Primary prevention
- Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels.[1][2].
- Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.
- By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
- Primary prevention of congenital complete heart block or second-degree AV block for women with SLE include taking hydroxychloroquine prior to conception.[3]
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM (May 2019). "Risk Factors Associated With Atrioventricular Block". JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ LEV M (November 1964). "ANATOMIC BASIS FOR ATRIOVENTRICULAR BLOCK". Am. J. Med. 37: 742–8. doi:10.1016/0002-9343(64)90022-1. PMID 14237429.
- ↑ Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). "The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices". Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.